Grifols (GRFS) secures a win in its defamation lawsuit against Gotham City Research in the U.S. Read more here.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 ...

Coherus Oncology, Inc. (Coherus Oncology, Nasdaq: CHRS), a commercial-stage innovative oncology company, formerly named Coherus BioSciences Inc., announced its name change today to better align with ...

Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (”Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, is rescheduling its intra-quarter webcast and investor update ...

The IDMO Smart Factory initiative has the potential to help advance the development and approval of CAR-T therapeutics in ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Housing, workforce development, education and child care were all topics during the Regen Valley Tech Hub Community Update, ...

Due to financial, logistical, and regulatory barriers, only two in 10 patients eligible for CAR T-cell therapy in the US ...

From 2011 to 2022, diagnoses rose 450% for adults ages 26 to 34. This has shown to be a relief to those who never understood their lifelong symptoms. In other news: AI can be used to determine the ...

Novi, Michigan anticipates a $270M mixed-use development with housing, a hotel, and retail, needing public funding.